News
1h
Axios on MSNSally Susman departs Pfizer after 18 yearsPfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...
Changing market conditions and consumer tastes and preferences have weighed on these businesses. Investors can learn a lot ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...
Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...
5don MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Achieve Life Sciences has signed up Omnicom to support the launch of nicotine dependence treatment cytisinicline, positioning ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
BRUSSELS (CNS) — European Commission President Ursula von der Leyen defended herself before the European Parliament Monday as ...
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
7d
Zacks Investment Research on MSNPfizer's Strong Late-Stage Pipeline Can Drive Long-Term GrowthPfizer PFE has committed significant resources for the development of treatments in the fields of oncology, internal medicine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results